Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3284babd59f13e5f8d0012df54dde5d4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_309fc743fd4529299614599357b75a58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e7547a4cdeaa71249c1a65b82ae9395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a62c3d83b91b3b5c392c1b202902cec http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e24952fca1fe54aebfc487740f7b67b1 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-689 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6895 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-701 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70 |
filingDate |
2020-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_823d24a41c38ae262e473e6f93ea72d5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23fa4aab967d43aca0cf93a93d59affd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9afd7ad91445206faf3a15231ba54c14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0417fc890f8f4abb66d6e17fd07a5fc |
publicationDate |
2022-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2022195539-A1 |
titleOfInvention |
Methods for Detecting Low Levels of Covid-19 Virus |
abstract |
Provided herein is a method for detecting the presence of a COVID-19 virus in a human sample or an environmental sample having one or more viral and bacterial pathogens. Samples processed to obtain total nucleic acids. The nucleic acids are used as a template in a reverse transcription-amplification reaction to obtain cDNA, which is used in a PCR amplification reaction to obtain fluorescent COVID-19 virus specific amplicons. These amplicons are detected by microarray hybridization near the lowest limit of detection. Also provided is a method for detecting in addition to the COVID-19 virus, the presence of respiratory disease-causing pathogens including viruses, bacteria and fungus in a single assay using the above method. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022267867-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11702709-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022251635-A1 |
priorityDate |
2020-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |